BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26821995)

  • 1. Postoperative chemoradiotherapy versus radiotherapy alone for cervical cancer: A systematic review and meta-analysis.
    Yang J; Yin J; Yan G; Huang D; Wang J
    J Obstet Gynaecol; 2016 Jul; 36(5):641-8. PubMed ID: 26821995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
    Jingjing H; Rui J; Hui P
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
    Li M; Hu M; Wang Y; Yang X
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():1-6. PubMed ID: 31082737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: A systematic review and meta-analysis.
    Yi L; Zhang H; Zou J; Luo P; Zhang J
    Gynecol Oncol; 2018 Jun; 149(3):612-619. PubMed ID: 29530332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Efficacy of Additional Concurrent Chemotherapy with Radiotherapy for Postoperative Cervical Cancer with Risk Factors: a Systematic Review and Meta-analysis.
    Qin AQ; Liang ZG; Ye JX; Li J; Wang JL; Chen CX; Song HL
    Asian Pac J Cancer Prev; 2016; 17(8):3945-51. PubMed ID: 27644643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
    Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
    Guo Q; Wang R; Jin D; Yin Z; Hu B; Li R; Wu D
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):15-23. PubMed ID: 35181028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

  • 9. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
    Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes.
    Chino J; Annunziata CM; Beriwal S; Bradfield L; Erickson BA; Fields EC; Fitch J; Harkenrider MM; Holschneider CH; Kamrava M; Leung E; Lin LL; Mayadev JS; Morcos M; Nwachukwu C; Petereit D; Viswanathan AN
    Gynecol Oncol; 2020 Dec; 159(3):607-610. PubMed ID: 32972783
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
    Li L; Song X; Liu R; Li N; Zhang Y; Cheng Y; Chao H; Wang L
    BMC Cancer; 2016 Jul; 16():403. PubMed ID: 27387204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis.
    Shim SH; Kim SN; Chae SH; Kim JE; Lee SJ
    J Gynecol Oncol; 2018 Mar; 29(2):e25. PubMed ID: 29400018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis.
    Lee KB; Shim SH; Lee JM
    J Gynecol Oncol; 2018 Jul; 29(4):e62. PubMed ID: 29770631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma.
    Luo H; Cui YY; Zhang JG; Sun YN; Zheng XL; Yang CL; Ye K; Ge H
    Clin Transl Oncol; 2018 Jul; 20(7):889-898. PubMed ID: 29143229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
    Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
    Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data.
    Fiorica F; Cartei F; Licata A; Enea M; Ursino S; Colosimo C; Cammà C
    Cancer Treat Rev; 2010 Nov; 36(7):539-49. PubMed ID: 20334979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
    Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
    Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
    Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.